Previous studies have indicated that blockade of CD137L reverse signaling promotes intra-tumoral differentiation of IFNγ-producing cytotoxic T cells, IL12-producing CD103+ DC, and type 1 tumor-associated macrophages to suppress tumor growth (13). Here, TNFSF9 is linked to neoplasm.